Log in to save to my catalogue

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolis...

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolis...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3102536628

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism

About this item

Full title

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism

Publisher

Ann Arbor: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2024-09, Vol.134 (17), p.1-18

Language

English

Formats

Publication information

Publisher

Ann Arbor: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Cytomegalovirus (CMV) is one of the most common and relevant opportunistic pathogens in people who are immunocompromised, such as kidney transplant recipients (KTRs). The exact mechanisms underlying the disability of cytotoxic T cells to provide sufficient protection against CMV in people who are immunosuppressed have not been identified yet. Here,...

Alternative Titles

Full title

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3102536628

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3102536628

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI179561.

How to access this item